Literature DB >> 25221581

Autophagy activation aggravates neuronal injury in the hippocampus of vascular dementia rats.

Bin Liu1, Jing Tang1, Jinxia Zhang1, Shiying Li1, Min Yuan1, Ruimin Wang1.   

Abstract

It remains unclear whether autophagy affects hippocampal neuronal injury in vascular dementia. In the present study, we investigated the effects of autophagy blockade on hippocampal neuronal injury in a rat model of vascular dementia. In model rats, hippocampal CA1 neurons were severely damaged, and expression of the autophagy-related proteins beclin-1, cathepsin B and microtubule-associated protein 1 light chain 3 was elevated compared with that in sham-operated animals. These responses were suppressed in animals that received a single intraperitoneal injection of wortmannin, an autophagy inhibitor, prior to model establishment. The present results confirm that autophagy and autophagy-related proteins are involved in the pathological changes of vascular dementia, and that inhibition of autophagy has neuroprotective effects.

Entities:  

Keywords:  autophagosomes; autophagy; beclin-1; cathepsin B; lysosomes; microtbuleassociated protein 1 light chain 3; nerve regeneration; neural regeneration; vascular dementia; wortmannin

Year:  2014        PMID: 25221581      PMCID: PMC4160855          DOI: 10.4103/1673-5374.137576

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN: 1673-5374            Impact factor:   5.135


Introduction

Autophagy is a basic catabolic mechanism by which unnecessary or dysfunctional cellular components are degraded by lysosomes; it is a specific, vital phenomenon of eukaryotic cells (Yorimitsu and Klionsky, 2005; Voigt and Pöggeler, 2013). Damaged organelles such as mitochondria are scavenged by autophagic processes to maintain the stability of nerve cells (Inoue et al., 2006; Bharadwaj et al., 2012). Excessive activation of autophagy leads to cell death (Kiffin et al., 2006; Chen et al., 2012). Previous studies have shown that autophagy is associated with senescence, malignant tumor growth, infection with pathogenic microorganisms, neurodegenerative disease, and diseases of the muscles and cerebrovascular system (Rubinsztein et al., 2005; Koike et al., 2008; Levine and Kroemer, 2008; Mizushima et al., 2008; Wen et al., 2008; Henriques-Pons and Nagaraju, 2009; Banerjee et al., 2010; Alger et al., 2011; Chang et al., 2012; Jia et al., 2012; Lynch-Day et al., 2012; Tung et al., 2012). However, few studies have explored the role of autophagy in the onset of vascular dementia. The autophagy inhibitor wortmannin is highly lipophilic, passing readily through the blood-brain barrier and cell membrane (Wipf and Halter, 2005). Cell culture experiments showed that wortmannin dose-dependently inhibits autophagy by blocking lysosomal transport substrates (Powis et al., 1994) with high selectivity (Fruman et al., 1998). In the present study, we sought to observe the changes in autophagy in the hippocampal CA1 region of a rat model of vascular dementia, and to investigate the effects of autophagy blockade on the onset of vascular dementia symptoms.

Materials and Methods

Animals

225 healthy male Sprague-Dawley rats, weighing 250–280 g (6–8 weeks old), were provided by Beijing HFK Bioscience Co., Ltd., Beijing, China (certificate No. SCXK (Jing) 2012-0013). All rats were housed in the Environmental Barrier Animal Laboratory, Hebei United University, China, at 23 ± 2°C, with natural illumination and free access to food and water. Animals were habituated to the housing conditions for 2 weeks prior to experimental procedures. This study was approved by the Ethics Committee of Hebei United University, China. The 225 rats were randomly and equally divided into a sham surgery group, a vascular dementia model group and a wortmannin group. Each group was randomly subdivided according to time points after model induction, i.e. 1, 2, 4, 8 and 12 weeks (n = 15 per subgroup). Within each subgroup, six rats were used for immunohistochemistry, six for western blot assay, and three for electron microscopy.

Wortmannin treatment

Rats in the wortmannin group received an intraperitoneal injection of an autophagy inhibitor wortmanninian (0.5 mg/kg; Beijing Biosynthesis Biotechnology Co., Ltd.). One hour after drug injection, surgery was performed to establish the vascular dementia model.

Vascular dementia model preparation

A rat model of vascular dementia was established using a modification of the Pulsinelli four-vessel occlusion method (Sibolt et al., 2013). The rats were fasted for 12 hours before surgery, then anesthetized intraperitoneally with 10% chloral hydrate (350 mg/kg; Beijing Biosynthesis Biotechnology Co., Ltd., Beijing, China). A median incision was made in the dorsal neck region to expose both transverse foramina of the first cervical vertebra. An electrocoagulation needle (0.5 mm in diameter) was inserted into each foramen for bilateral cauterization of the vertebral artery, resulting in permanent occlusion. The rats were fixed in the supine position, and a median ventral neck incision was made to isolate the common carotid artery bilaterally. The wound was sutured and the rats remained under anesthesia for 24 hours, before the artery was occluded three times, by clamping for 5 minutes at hourly intervals. The surgical site was sprayed with gentamicin to prevent infection and the skin was sutured. The sham-operated group underwent the same procedures as the model groups, but ischemia was not carried out. After surgery, all rats were treated with gentamicin for 3 consecutive days to prevent infection.

Behavioral assessment of learning and memory

A Morris water maze (Huaibei Zhenghua Biologic Apparatus Facilities Co., Ltd., Huaibei, Anhui Province, China), 120 cm in diameter, was used. A circular platform (23 cm high and 10 cm in diameter) was placed in the center of a quadrant, 2 cm below the surface of the water. The water temperature was 24 ± 2°C and the room temperature was 24°C. Behavioral assessment was carried out at 1, 2, 4, 8 and 12 weeks after modeling. Five days of navigation tests were performed before a probe test on the sixth day. Navigation tests consisted of two sessions per day (morning and afternoon), each with four trials. Each trial began when the rat was released into the water at one of four release points with its face toward the pool wall. The time taken for the rat to find and climb the platform was recorded as the escape latency. When the rat found the platform within 120 seconds, it was allowed to remain on the platform for 30 seconds, before a 60 second break in the home cage. If the rat failed to climb onto the platform within 120 seconds, it was manually guided onto the platform and allowed to stay there for 30 seconds before the break. The escape latency was recorded as 120 seconds in such cases. In the spatial probe test on day 6, the platform was removed from the pool. The rat was released into the water with its face toward the pool wall and the number of times it crossed the area in which the platform was previously located was recorded over a period of 120 seconds.

Transmission electron microscopy of the hippocampus

Three rats per group were deeply anesthetized with 10% chloral hydrate (0.3 mL/100 g), and the tissue was fixed with 4% paraformaldehyde and 2.5% glutaral. The rats were decapitated, the brains removed, and the hippocampi cut coronally into blocks (1 mm3). Specimens were post-fixed in 2.5% glutaral, and sliced into ultrathin sections (50–70 nm). Ultrastructure changes were observed under a transmission electron microscope (H-7650; Hitachi, Tokyo, Japan).

Immunohistochemistry of beclin-1 and cathepsin B in the hippocampal CA1 region

Rats were deeply anesthetized with 10% chloral hydrate (0.3 mL/100 g) and decapitated. Brains were removed on ice and placed in 4% paraformaldehyde in phosphate buffer for at least 24 hours after fixation. The portion of the brain containing the hippocampus was cut coronally into slices approximately 2 mm thick. The slices were embedded in paraffin and sectioned using a microtome (Jung Histocut, model 820-II, Leica, Wetzlar, Germany), dewaxed in xylene, dehydrated through an alcohol gradient, and immersed in pH 6.0 sodium citrate buffer and boiled for antigen retrieval. After cooling to room temperature, the sections were washed three times with PBS (5 minutes each wash), and incubated with rabbit anti-beclin-1 (1:500; Beijing Biosynthesis Biotechnology Co., Ltd.) and anti-cathepsin B (1:500; Beijing Biosynthesis Biotechnology Co., Ltd.) antibodies at 4°C overnight. The sections were then washed three times with PBS as before, incubated with goat anti-rabbit IgG (1:2,000; Beijing Biosynthesis Biotechnology Co., Ltd.) at 37°C for 30 minutes, washed again three times with PBS, and visualized with freshly prepared 3,3′-diaminobenzidine. They were then counterstained with hematoxylin, permeabilized, and mounted. The number of immunopositive cells in the hippocampal CA1 region was counted in six non-overlapping visual fields observed under a high-power lens (200 × magnification; Hitachi, Japan). A cell was counted as positive if its nucleus was stained royal blue and its cytoplasm was stained yellow or brown.

Western blot assay of light chain 3 protein expression in the hippocampus

Light chain 3 is a protein marker of autophagy (Kanno et al., 2011). Rats were deeply anesthetized with 10% chloral hydrate (0.3 mL/100 g), and decapitated. Brains were removed on ice and washed with cold PBS. Hippocampi were isolated immediately, placed in a 15 mL centrifuge tube and homogenized at 12,000 r/min (r = 3 cm) for 15 seconds using a rotary homogenizer. Each subsequent stage was performed at 4°C unless stated otherwise. The samples were treated with lysis buffer, shaken, and incubated for 30 minutes. The cell suspension was centrifuged at 12,000 r/min for 10 minutes and the supernatant was kept. After quantitation, protein concentration was adjusted to 750 μg/mL with PBS and an equal volume of loading buffer was added. The specimens were boiled in water for at least 5 minutes. A bicinchoninic acid kit (Beijing Biosynthesis Biotechnology Co., Ltd.) was used to determine protein concentrations against a standard curve, according to the manufacturer's instructions. Samples (50 μg total protein in each lane) were electrophoresed in sodium dodecyl sulfate-polyacrylamide gel, and electrically transferred to polyvinylidene fluoride membranes using the wet method (Hahn et al., 2011). The transfer buffer contained glycine 5.8 g, Tris 2.9 g and sodium dodecyl sulfate 0.37 g dissolved in 800 mL redistilled water and 200 mL methanol. Subsequently, the membranes were blocked in 5% non-fat dry milk, incubated with rabbit anti-rat light chain 3 monoclonal antibody (1:1,000; Beyotime Institute of Biotechnology, Beijing, China) at 4°C overnight, washed with PBS, incubated with goat anti-rabbit IgG (1:2,000; Beijing Biosynthesis Biotechnology Co., Ltd.) at 37°C for 1 hour, and washed again with PBS. Protein bands were visualized using enhanced chemiluminescence and film exposure (Pierce, Rockford, IL, USA). Results were analyzed using Image J software (National Institutes of Health, Bethesda, MD, USA).

Statistical analysis

Data were collected with Excel 2007 software (Microsoft Corporation, Redmond, WA, USA), analyzed using SPSS 17.0 software (SPSS, Chicago, IL, USA), and expressed as mean ± SD. One-way analysis of variance was used to identify differences between multiple groups, and two-sample t-tests were used to compare means between two groups. A value of P < 0.05 was considered statistically significant.

Results

Effect of autophagy blockade on learning and memory in vascular dementia model rats

In the Morris water navigation test (), no significant differences in the time to reach the platform (average escape latency) were observed between the groups at 1 or 2 days (P > 0.05). However, from day 3, the average escape latency was longer in the vascular dementia group than in the sham surgery group (P < 0.05 or P < 0.01). Furthermore, escape latency in the wortmannin group was significantly shorter than that in the vascular dementia model group (P < 0.05). Effect of autophagy blockade on the escape latency (second) of vascular dementia model rats in the Morris water navigation task In the spatial probe test (), rats in the vascular dementia model group made significantly fewer crossings of the platform area than rats in the sham surgery group (P < 0.05 or P < 0.01), whereas rats in the wortmannin group crossed the platform area significantly more times than those in the vascular dementia group (P < 0.05 or P < 0.01). Effect of autophagy blockade on the number of platform area crossings (/120 seconds) made by vascular dementia model rats in the probe test of the Morris water navigation task

Effect of autophagy blockade on the ultrastructure of the hippocampal CA1 region in vascular dementia model rats

Under the transmission electron microscope, neurons in the hippocampal CA1 region of rats in the sham surgery group () showed evident nuclei with uniformly distributed chromatin. Cytoplasmic organelles were abundant and their structures were intact. Mitochondria were not swollen. No autophagosomes were visible. In rats in the vascular dementia model group, at 1 and 2 weeks (), electron density of the neuronal cytoplasm was greater than that in sham-operated rats. Nuclear membrane collapse and nuclear condensation were visible. There were few normal mitochondria, with most exhibiting vacuolar degeneration. The rough endoplasmic reticulum was expanded, vacuolization appeared around nuclei, and polysome depolymerization and a high degree of swelling were visible. Cellular organelles were sparse. Round autophagosomes were located next to nuclei and there were a large number of primary lysosomes. At 4 and 8 weeks (), autophagosomes and lysosomes were abundant. Some residual mitochondria coated by autophagosomes were detectable, and autophagy was evident. Autophagosomes could also be seen at 12 weeks (). In the hippocampal CA1 region of rats in the wortmannin group (), degeneration occurred in some nerve cells but there was less neuronal injury than in the model group at all time points. Staining was weak. Nuclear shrinkage, edema and mitochondrial swelling were not apparent. Rough endoplasmic reticulum was normal. Autophagy occurred, but the number of autophagosomes was less than that in the model group. Effect of autophagy blockade on the ultrastructure of hippocampal CA1 neurons in vascular dementia model rats (transmission electron microscopy, × 25,000). (A) Sham surgery group, no observable autophagosomes. (B–F) Vascular dementia group, autophagosomes (arrows) appeared at 1, 2, 4, 8 and 12 weeks after modeling. (G–K) Wortmannin group, fewer autophagosomes (arrows) were visible than in the vascular dementia group at 1, 2, 4, 8 and 12 weeks after model induction.

Effect of autophagy blockade on beclin-1 and cathepsin B expression in the hippocampal CA1 region of vascular dementia model rats

Immunohistochemistry showed that beclin-1 and cathepsin B expression was low at the various time points in the hippocampal CA1 region of rats in the sham surgery group. However, in the vascular dementia group, expression of both proteins was greater than that in sham-operated animals at 1 week. Expression levels peaked at 4 weeks and began to decrease at 8 weeks but were still elevated at 12 weeks compared with the levels observed in sham-operated rats (P < 0.05 or P < 0.01). Beclin-1 protein and cathepsin B protein expression was lower in the wortmannin group than in the vascular dementia group at all time points (P < 0.05 or P < 0.01; , Tables ). Effect of autophagy blockade on beclin-1 (A) and cathepsin B (B) expression in the hippocampal CA1 region of vascular dementia model rats (immunohistochemistry, × 200). Sham surgery group (Sham), few beclin-1- and cathepsin B-positive cells; vascular dementia group (VD), more beclin-1- and cathepsin B-positive cells, peaking at 4 weeks after model induction; wortmannin group (WM), fewer beclin-1- and cathepsin B-positive cells than in the vascular dementia group. Arrows show immunopositive cells. Effect of autophagy blockade on beclin-1 expression (number of immunopositive cells) in the hippocampal CA1 region of vascular dementia model rats Effect of autophagy blockade on cathepsin B expression (number of immunopositive cells) in the hippocampal CA1 region of vascular dementia model rats

Effect of autophagy blockade on microtubule-associated protein 1 light chain 3 (light chain 3-II/light chain 3-I ratio) in the hippocampal CA1 region of vascular dementia model rats

Western blot assay revealed that a small quantity of light chain 3 protein was present in the hippocampal CA1 region of rats in the sham surgery group, and the light chain 3-II/ light chain 3-I ratio was low. In the vascular dementia group, the light chain 3-II/light chain 3-I ratio was greater than that in the sham-operated group at 1 week, peaked at 4 weeks, began to diminish at 8 weeks, and was still elevated at 12 weeks compared with the sham-operated group (P < 0.05 or P < 0.01). In the wortmannin group, the light chain 3-II/ light chain 3-I ratio was lower than that in the vascular dementia group at all time points (P < 0.05 or P < 0.01; , ). Effect of autophagy blockade on the expression of microtubule-associated protein 1 light chain 3 (LC3) in the hippocampal CA1 region of vascular dementia model rats (western blot assay). (A) Sham surgery group; (B) vascular dementia group; (C) wortmannin group. 1–5: 1, 2, 4, 8 and 12 weeks after modeling. Effect of autophagy on the expression of microtubule-associated protein 1 light chain 3 (LC3) (LC3-II/LC3-I ratio) in the hippocampal CA1 region of vascular dementia model rats

Discussion

Vascular dementia is primarily caused by cerebrovascular disease, specifically recurrent cerebral ischemia (Pulsinelli et al., 1982). In the present study, we established a rat model of vascular dementia using a modification of the Pulsinelli four-vessel occlusion method, which severely reduced the blood supply to the brain, simulating the pathogenic process of human vascular dementia and resulting in a decrease in nerve cell functions and impaired learning and memory. The Pulsinelli method is an established technique for producing vascular dementia models. A previous study demonstrated that neurons in different cerebral regions had different sensitivities to ischemia, with the hippocampus being the most sensitive (Hölscher, 2003). The CA1 region of the hippocampus is strongly associated with spatial discrimination, learning and memory (Hölscher, 2003; Lin et al., 2014). Neuronal injury in the CA1 region affects individual learning and memory functions (Vorhees and Williams, 2006; Foster, 2012). In the present study, we tested learning and memory in rats and showed that performance in the Morris water maze was significantly impaired in vascular dementia model rats. Thus, the model rats used in this study met the criteria for vascular dementia models, confirming the success of the model. After injection of wortmannin, an inhibitor of autophagy, escape latency was shorter in the navigation tests, and rats crossed the platform area more times in the probe test, than rats in the vascular dementia model group, indicating that inhibition of autophagy prevented the impairment of learning and memory seen in the vascular dementia model rats. Autophagy is a self-degradative process that is important for balancing sources of energy. It involves lysosomal-dependent recycling, synthesis and degradation of intracellular components (Reggiori and Klionsky, 2002; Jung and Lee, 2010), thus maintaining the stability of the internal environment (Kanki and Klionsky, 2010; Novak and Dikic, 2011; Lee et al., 2012). During this process, targeted cytoplasmic constituents are isolated from the rest of the cell within the autophagosomes, which are then fused with lysosomes and degraded or recycled (Reggiori and Klionsky, 2002). The formation of the autophagosome is essential in the detection of autophagy, and electron microscopy is the gold standard method by which to observe autophagosomes (Mizushima, 2004). In the present study, electron microscope images revealed ultrastructural changes in the hippocampal CA1 neurons of rats in the sham surgery group, with the presence of autophagy. However, in the wortmannin group, there was less neuronal injury, and although autophagy occurred, there were fewer autophagosomes than in the model group. These results demonstrate that autophagy and significant changes in neuronal ultrastructure occur in the hippocampal CA1 region of vascular dementia model rats. Beclin-1, highly homologous with yeast autophagy-related gene 6 (Apg6/Vps30), is essential to the induction and regulation of autophagy (Aita et al., 1999; Liang et al., 2001). It is the earliest autophagic gene found in mammals, and can regulate autophagic activity by binding to phosphatidylinositol 3-kinase type 3 (Edinger and Thompson, 2003; Scarlatti et al., 2008). Previous studies have demonstrated that upregulation of beclin-1 promotes autophagic activity (Liang et al., 1999; Qu et al., 2003; Yue et al., 2003). Autophagic activity is reduced in cells with low beclin-1 expression (Yue et al., 2002; Yue et al., 2003). In the adult mammal brain, beclin-1 is expressed in neurons and astrocytes (Liang et al., 1998) in the cerebral cortex, hippocampus and cerebellum (Yue et al., 2002). Another study showed that beclin-1 was strongly associated with the anti-apoptotic factor Bcl-2 (Kim et al., 2006). The binding of beclin-1 to Bcl-2 functions as a defense system, suppressing cell autophagy and reducing apoptosis in the central nervous system. Moreover, enzymes in the lysosomes of eukaryotic cells are involved in cell metabolism (Qin et al., 2008). For example, cellular organelles surrounded by autophagosomes are degraded by lysosomal enzymes. Cathepsin is a major lysosomal enzyme (Diskin et al., 2005), comprising three forms of protease: cysteine protease (including cathepsin B, F, H and K), aspartate protease (cathepsin D and E), and serine protease (cathepsin A and G). Cathepsin is associated with the occurrence and development of various nervous system diseases (Kikuchi et al., 2003; Pišlar and Kos, 2014). A previous study reported that cathepsin B and cathepsin L are important for maintaining the normal function of the central nervous system (Turk et al., 2002). Results from the present study showed that protein expression of beclin-1 and cathepsin B was significantly greater in the vascular dementia group than in the sham surgery group, whereas expression of both proteins was lower in the wortmannin group than in the vascular dementia group. These results indicate that hippocampal expression of autophagy-related beclin-1 and cathepsin B proteins is increased following ischemic injury, and may play a role in the onset and development of vascular dementia. Autophagy is an adaptation reaction of cells to stress produced by alterations in the internal and external environments. Stimulating factors trigger autophagic genes and induce an increase in the expression of related protein products. This results in the formation of autophagosomes and lysosomes and an increase in the expression of proteins related to autophagiclysosomal pathways (Levine and Klionsky, 2004; Meijer and Codogno, 2004; Todde et al., 2009). Light chain 3 is the first autophagosome membrane protein found in eukaryotic cells and is a characteristic marker of autophagy (Kanno et al., 2011). It exists as light chain 3-I and light chain 3-II. Light chain 3-I is soluble, with a molecular weight of 18 kDa. It is the form of light chain 3 found before autophagy, and is mainly distributed in the cytoplasm (Tanida et al., 2004). The molecular weight of light chain 3-II is 16 kDa. Light chain 3-II is produced by binding light chain 3-I after ubiquitin-like modification to phosphatidylethanolamine on the surface of autophagic membranes. Light chain 3-II is located in the preautophagosome and autophagosome, and serves as an autophagosomal marker. The light chain 3-II/ light chain 3-I ratio is associated with the number of autophagic vacuoles (Alonso et al., 2007). Western blot assay of light chain 3-II or light chain 3-II/light chain 3-I ratio is a simple and relatively quantitative method for evaluating autophagic activity (Cherra et al., 2010). Results from the present study demonstrated that the light chain 3-II/light chain 3-I ratio was greater in the hippocampal CA1 region of rats in the vascular dementia group than in the sham-operated group, but that this difference was reduced in rats that had received wortmannin. These results indicate that autophagic processes were activated in the hippocampus of vascular dementia model rats after ischemic injury, and suggest that autophagy is involved in the onset of vascular dementia. The autophagy inhibitor wortmannin is a specific inhibitor of phosphatidylinositol 3-kinase, blocking the phosphatidylinositol 3-kinase/Akt signaling pathway inside the cell and reducing the occurrence of autophagy (Carloni et al., 2008). Our results confirmed that autophagy is activated in the hippocampus of vascular dementia model rats, suggesting its involvement in the onset of vascular dementia. Wortmannin reduced vascular dementia-induced hippocampal injury by suppressing autophagic activity, and showed neuroprotective effects. Our results suggest a novel pathway and target for drug treatment of vascular dementia.
Table 1

Effect of autophagy blockade on the escape latency (second) of vascular dementia model rats in the Morris water navigation task

Table 2

Effect of autophagy blockade on the number of platform area crossings (/120 seconds) made by vascular dementia model rats in the probe test of the Morris water navigation task

Table 3

Effect of autophagy blockade on beclin-1 expression (number of immunopositive cells) in the hippocampal CA1 region of vascular dementia model rats

Table 4

Effect of autophagy blockade on cathepsin B expression (number of immunopositive cells) in the hippocampal CA1 region of vascular dementia model rats

Table 5

Effect of autophagy on the expression of microtubule-associated protein 1 light chain 3 (LC3) (LC3-II/LC3-I ratio) in the hippocampal CA1 region of vascular dementia model rats

  57 in total

Review 1.  Defective autophagy leads to cancer.

Authors:  Aimee L Edinger; Craig B Thompson
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

Review 2.  Methods for monitoring autophagy.

Authors:  Noboru Mizushima
Journal:  Int J Biochem Cell Biol       Date:  2004-12       Impact factor: 5.085

Review 3.  Oxidative stress and autophagy.

Authors:  Roberta Kiffin; Urmi Bandyopadhyay; Ana Maria Cuervo
Journal:  Antioxid Redox Signal       Date:  2006 Jan-Feb       Impact factor: 8.401

Review 4.  Autophagy: principles and significance in health and disease.

Authors:  Virginia Todde; Marten Veenhuis; Ida J van der Klei
Journal:  Biochim Biophys Acta       Date:  2008-11-05

5.  Closed head injury induces upregulation of Beclin 1 at the cortical site of injury.

Authors:  Tal Diskin; Pazit Tal-Or; Shlomit Erlich; Liat Mizrachy; Alexander Alexandrovich; Esther Shohami; Ronit Pinkas-Kramarski
Journal:  J Neurotrauma       Date:  2005-07       Impact factor: 5.269

6.  The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage.

Authors:  Heather M Alger; Nina Raben; Emidio Pistilli; Dwight L Francia; Rashmi Rawat; Derese Getnet; Svetlana Ghimbovschi; Yi-Wen Chen; Ingrid E Lundberg; Kanneboyina Nagaraju
Journal:  Arthritis Rheum       Date:  2011-11

7.  Induction of autophagy and autophagic cell death in damaged neural tissue after acute spinal cord injury in mice.

Authors:  Haruo Kanno; Hiroshi Ozawa; Akira Sekiguchi; Seiji Yamaya; Eiji Itoi
Journal:  Spine (Phila Pa 1976)       Date:  2011-10-15       Impact factor: 3.468

Review 8.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

9.  Regulation of the autophagy protein LC3 by phosphorylation.

Authors:  Salvatore J Cherra; Scott M Kulich; Guy Uechi; Manimalha Balasubramani; John Mountzouris; Billy W Day; Charleen T Chu
Journal:  J Cell Biol       Date:  2010-08-16       Impact factor: 10.539

10.  Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cells.

Authors:  Li Jia; Ganga Gopinathan; Johanna T Sukumar; John G Gribben
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

View more
  9 in total

1.  The Role of Autophagy in the Correlation Between Neuron Damage and Cognitive Impairment in Rat Chronic Cerebral Hypoperfusion.

Authors:  Wenying Zou; Yufei Song; Yumei Li; Yu Du; Xiaojie Zhang; Jianliang Fu
Journal:  Mol Neurobiol       Date:  2017-01-05       Impact factor: 5.590

2.  Estrogen Exerts Neuroprotective Effects in Vascular Dementia Rats by Suppressing Autophagy and Activating the Wnt/β-Catenin Signaling Pathway.

Authors:  Yanyan Yang; Lei Zhao; Na Li; Congwei Dai; Nan Yin; Zhaoping Chu; Xiaoyan Duan; Xiaoli Niu; Ping Yan; Peiyuan Lv
Journal:  Neurochem Res       Date:  2020-07-27       Impact factor: 4.414

3.  Phytochemical analysis of hydroethanolic extract of Turnera diffusa Willd and evaluation of its effects on astrocyte cell death.

Authors:  Andréia Gomes Bezerra; Giuseppina Negri; Joaquim Maurício Duarte-Almeida; Soraya Soubhi Smaili; Elisaldo Araújo Carlini
Journal:  Einstein (Sao Paulo)       Date:  2016 Jan-Mar

4.  Inhibition of Phosphatidylinositol 3-kinease suppresses formation and progression of experimental abdominal aortic aneurysms.

Authors:  Jing Yu; Rui Liu; Jianhua Huang; Lixin Wang; Wei Wang
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

5.  Effects of imperatorin on apoptosis and synaptic plasticity in vascular dementia rats.

Authors:  Ying Huang; Xiangping Liao; Huaiwei Wang; Jianghong Luo; Shanquan Zhong; Ziliang Zhang; Fang Zhang; Jianping Chen; Fuhua Xie
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

Review 6.  Progress in the Mechanism of Autophagy and Traditional Chinese Medicine Herb Involved in Dementia.

Authors:  Pengyu Tao; Jing Ji; Simeng Gu; Qian Wang; Yuzhen Xu
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

7.  MicroRNA-210-5p Contributes to Cognitive Impairment in Early Vascular Dementia Rat Model Through Targeting Snap25.

Authors:  Zhenxing Ren; Junlong Yu; Zimei Wu; Wenwen Si; Xianqian Li; Yuqing Liu; Jianhong Zhou; Rudong Deng; Dongfeng Chen
Journal:  Front Mol Neurosci       Date:  2018-11-13       Impact factor: 5.639

8.  Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons.

Authors:  Jessica L Binder; Praveen Chander; Vojo Deretic; Jason P Weick; Kiran Bhaskar
Journal:  PLoS One       Date:  2020-03-24       Impact factor: 3.240

Review 9.  Structural Plasticity of the Hippocampus in Neurodegenerative Diseases.

Authors:  Poornima D E Weerasinghe-Mudiyanselage; Mary Jasmin Ang; Sohi Kang; Joong-Sun Kim; Changjong Moon
Journal:  Int J Mol Sci       Date:  2022-03-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.